References

The rising global burden of MASLD and other metabolic diseases (2000-2021)

10.1002/ueg2.70072 · 2025 · External reference

Mechanisms and disease consequences of nonalcoholic fatty liver disease

10.1016/j.cell.2021.04.015 · 2021 · External reference

Integrating the environmental and genetic architectures of aging and mortality

10.1038/s41591-024-03483-9 · 2025 · External reference

Environmental risk factors for liver cancer and nonalcoholic fatty liver disease

10.1007/s40471-019-0183-2 · 2019 · External reference

Air pollution deaths attributable to fossil fuels: observational and modelling study

10.1136/bmj-2023-077784 · 2023 · External reference

Mapping the association between environmental pollutants and steatotic liver disease: a systematic review and meta-analysis

10.1016/j.envres.2025.122623 · 2025 · External reference

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

10.1038/s42255-023-00775-1 · 2023 · External reference

Dissecting metabolic dysfunction- and alcohol-associated liver disease (MetALD) using proteomic and metabolomic profiles

10.1016/j.jhep.2025.05.026 · 2025 · External reference

Subacute PM2.5 exposure induces hepatic insulin resistance through inflammation and oxidative stress

2025 · External reference

Air pollution and systemic inflammation in patients with suspected OSA living in an urban residential area

10.1016/j.chest.2020.05.596 · 2020 · External reference

Association of metabolic signatures of air pollution with MASLD: observational and mendelian randomization study

10.1016/j.jhep.2024.09.033 · 2025 · External reference

Large-scale plasma proteomics uncovers novel targets linking ambient air pollution and depression

10.1038/s41380-025-02953-x · 2025 · External reference

Plasma proteome mediates the associations between air pollution exposure and disease risk

2026 · External reference

Revisiting biomarker discovery by plasmaproteomics

10.15252/msb.20156297 · 2017 · External reference

Noninvasive proteomic biomarkers for alcohol-related liver disease

10.1038/s41591-022-01850-y · 2022 · External reference

Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis

10.1016/j.ebiom.2024.105532 · 2025 · External reference

Mechanisms of NAFLD development and therapeutic strategies

10.1038/s41591-018-0104-9 · 2018 · External reference

Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease

10.15252/msb.20188793 · 2019 · External reference

Plasma proteomic associations with genetics and health in the UK Biobank

10.1038/s41586-023-06592-6 · 2023 · External reference

Proteomic signature of dementia risk in type 2 diabetes

2025 · External reference

Alzheimer's Disease polygenic risk, the plasma proteome, and dementia incidence among UK older adults

10.1007/s11357-024-01413-8 · 2025 · External reference

Quality control and removal of technical variation of NMR metabolic biomarker data in ∼120,000 UK Biobank participants

10.1038/s41597-023-01949-y · 2023 · External reference

Exposure to air pollution during pre-hypertension and subsequent hypertension, cardiovascular disease, and death: a trajectory analysis of the UK biobank cohort

10.1289/ehp10967 · 2023 · External reference

Disconnection of network hubs and cognitive impairment after traumatic brain injury

10.1093/brain/awv075 · 2015 · External reference

Metabolic signature of healthy lifestyle and risk of rheumatoid arthritis: observational and mendelian randomization study

10.1016/j.ajcnut.2023.04.034 · 2023 · External reference

The Mediterranean diet, plasma metabolome, and cardiovascular disease risk

10.1093/eurheartj/ehaa209 · 2020 · External reference

Steroid receptor coactivator-1 facilitates METTL3-mediated m6A modification by coactivating NF-kappaB and promotes the malignant progression of glioblastoma

10.1038/s41388-025-03494-x · 2025 · External reference

Biomass fuel induces neuroinflammation and neurodegeneration via the astrocyte-microglia IL-17A/IL-17RA pathway

10.1016/j.jhazmat.2025.138569 · 2025 · External reference

Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia

10.1016/j.freeradbiomed.2018.11.016 · 2019 · External reference

Chemokines and chemokine receptors in the development of NAFLD

10.1007/978-981-10-8684-7_4 · 2018 · External reference

Integrated profiling of adiponectin and cytokine signaling pathways in high-fat diet-induced MASLD reveals early markers of disease progression

10.1038/s41598-025-02001-2 · 2025 · External reference

Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2

10.1152/ajpgi.00365.2011 · 2012 · External reference

CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice

10.1016/j.metabol.2021.154914 · 2021 · External reference

Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets

10.1002/hep.31031 · 2020 · External reference

Associations of exposure to fine particulate matter mass and constituents with systemic inflammation: a cross-sectional study of urban older adults in China

10.1021/acs.est.1c04488 · 2022 · External reference

The acute effects of fine particulate matter constituents on blood inflammation and coagulation

10.1021/acs.est.7b00312 · 2017 · External reference

10.20944/preprints202205.0252.v1

10.20944/preprints202205.0252.v1 · External reference

MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury

10.1016/j.jhep.2013.12.022 · 2014 · External reference

Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis

10.1186/s12864-025-11668-w · 2025 · External reference

Exposure to ambient air pollution and elevated blood levels of gamma-glutamyl transferase in a large Austrian cohort

10.1016/j.scitotenv.2023.163658 · 2023 · External reference

Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway

10.1016/j.intimp.2025.115304 · 2025 · External reference

Inhibition of DDR1 potentiates carbon ion radiotherapy by promoting ferroptosis and immunogenic death in head and neck squamous cell carcinoma

10.1186/s12967-025-07062-5 · 2025 · External reference

CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes

10.1016/j.imlet.2013.12.020 · 2014 · External reference

Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study

2025 · External reference

Analysis of the genetic relationship between atherosclerosis and non-alcoholic fatty liver disease through biological interaction networks

10.3390/ijms24044124 · 2023 · External reference

Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization

10.18632/oncotarget.18967 · 2017 · External reference

Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice

10.1038/s41423-018-0032-0 · 2019 · External reference

Disturbance of mitochondrial functions caused by N-acetylglutamate and N-acetylmethionine in brain of adolescent rats: potential relevance in aminoacylase 1 deficiency

10.1016/j.neuint.2023.105631 · 2023 · External reference

Proteomic profiling of plasma to uncover novel intervention targets and prognostic biomarkers for chronic liver diseases

10.1111/dom.70696 · 2026 · External reference

Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese

2023 · External reference

IKK-beta links inflammation to obesity-induced insulin resistance

10.1038/nm1185 · 2005 · External reference

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

10.1038/nature13478 · 2014 · External reference

Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases

10.1016/j.cmet.2017.08.002 · 2018 · External reference

Metabolic regulation of the immune system in health and diseases: mechanisms and interventions

10.1038/s41392-024-01954-6 · 2024 · External reference

Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications

10.1016/j.jhep.2016.04.005 · 2016 · External reference

High-density lipoprotein modifications: a pathological consequence or cause of disease progression?

10.3390/biomedicines8120549 · 2020 · External reference

Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways

10.1186/s12876-025-03632-5 · 2025 · External reference

The paraoxonase (PON) gene family in health, metabolic dysfunction-associated steatotic liver disease (MASLD) and other diseases

10.3390/ijms262211054 · 2025 · External reference

10.1021/acssensors.0c01524

10.1021/acssensors.0c01524 · External reference

PM2.5 induces liver fibrosis via triggering ROS-mediated mitophagy

10.1016/j.ecoenv.2018.08.050 · 2019 · External reference

Multi-omics reveals hypertrophy of adipose tissue and lipid metabolism disorder via mitochondria in young mice under real-ambient exposure to air pollution

10.3389/fphar.2023.1122615 · 2023 · External reference